PHILADELPHIA, Feb. 2 /PRNewswire-FirstCall/ -- On Thursday, February 8th, GlaxoSmithKline plc will announce its Q4 and full year financial results for 2006. A press release is scheduled for distribution at approximately 7:00 a.m. Eastern Standard Time (EST) on the 8th, and will be available at http://www.gsk.com.
A media briefing, originating in London, will begin at 7:15 a.m. (EST), led by JP Garnier, CEO. US media are invited to phone in to listen to the briefing. Presentation slides will be available on http://www.gsk.com. A replay of the media briefing will also be available for one week after the event. Dial in numbers are as follows:
US Toll Free Dial in Number: 1 866 966 7410 International Dial in Number: +44 (0) 1452 561 164 Replay Access Number: 7133424# US Toll Free Dial In: 1 866 247 4222
At 9:00 a.m. (EST), GSK will host a live webcast presentation to investors and analysts with JP Garnier, CEO; Julian Heslop, CFO; and David Stout, President, Pharmaceutical Operations. Slides will be available on http://www.gsk.com. Please click on the link below to register for the meeting no later than Monday, February 5th:
https://survey.gsk.com/TakeSurvey.asp?SurveyID=521m54K02651K The dial in number to listen to the webcast is: US Toll Free: 1 866 966 9441
A recording of the analyst teleconference will be available at the following number:
US Toll Free: 1 866 247 4222
Passcode: 8461808#
GlaxoSmithKline plc
CONTACT: US Media Inquiries: Nancy Pekarek, +1-215-751-7709, or Mary AnneRhyne, +1-919-483-2839, or Patricia Seif, +1-215-751-7709, all ofGlaxoSmithKline
Web site: http://www.gsk.com/
Company News On-Call: http://www.prnewswire.com/comp/801350.html/
